ADVIA Centaur and Atellica IM PSA
FDA premarket approval P950021/S020 · decided 2020-03-19
Approval details
- PMA number
- P950021
- Supplement
- S020
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- ADVIA Centaur and Atellica IM PSA
- Generic name
- Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
- Applicant
- Siemens Healthcare Diagnostics
- Date received
- 2020-02-21
- Decision date
- 2020-03-19
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- MTF
- Advisory committee
- Immunology
- Expedited review
- No
- Location
- East Walpole, MA
- Statement
- Scale-up and implementation of a common mixing process for all kit bulk reagents.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.